Forschungs- & Entwicklungsinformationsdienst der Gemeinschaft - CORDIS

Informationen von Horizont-2020-Projekten und nun auch Berichtzusammenfassungen stehen jetzt auf CORDIS bereit. Alle H2020-Projekte können jetzt vom Offenen Datenportal der EU heruntergeladen werden.

My refinements

Download results of this page

Filtern nach:




Projekt (7)

Advanced search

Nach Projekten und Ergebnissen suchen

Results 1 - 7 of 7
Discovery and preclinical development of new generation tuberculosis vaccines
ID: 241745
Anfangsdatum: 2010-01-01, Enddatum: 2014-02-28
With 14.4 million prevalent cases and 1.7 million deaths tuberculosis (TB) remains one of the most serious infectious diseases to date. An estimated 2 billion people are believed to be infected with Mycobacterium tuberculosis and at risk of developing disease. Multi- and exte...
Programme: FP7-HEALTH
Record Number: 93343
Last updated on: 2017-06-05
Small-molecule Inhibitor Leads Versus emerging and neglected RNA viruses
ID: 260644
Anfangsdatum: 2010-10-01, Enddatum: 2015-03-31
RNA virus infections kill millions of humans annually, largely due to the lack of suitable vaccines and drugs to control them. This problem is addressed in this FP7 call and in response a consortium of Europe’s and Asia’s leading molecular virologists, structural biologists, ...
Programme: FP7-HEALTH
Record Number: 96747
Last updated on: 2017-08-27
Targeting the Leishmania kinome for the development of novel anti-parasitic strategies
ID: 223414
Anfangsdatum: 2008-10-01, Enddatum: 2012-03-31
Visceral leishmaniasis is caused by the protozoan parasites Leishmania donovani and Leishmania infantum and is a potentially fatal disease in endemic areas around the world. During the infectious cycle, Leishmania alternate between the insect promastigote stage and the verteb...
Programme: FP7-HEALTH
Record Number: 88852
Last updated on: 2017-05-29
Open Collaborative Model for Tuberculosis Lead Optimisation
ID: 261378
Anfangsdatum: 2011-01-01, Enddatum: 2015-06-30
"Early stage Drug Discovery efforts over the last 5 years have resulted in the identification of a number of promising lead compounds in the fight against TB. These leads need to be further progressed and optimised into candidates for pre-clinical development through the Drug...
Programme: FP7-HEALTH
Record Number: 96802
Last updated on: 2017-05-26
Mycobacterium tuberculosis W-Beijing genetic diversity and differential virulence and host immune responses
ID: 200973
Anfangsdatum: 2008-04-01, Enddatum: 2011-03-31
Improvements in TB control require the development of new tools for rapid and accurate diagnosis and intervention. This development is likely to benefit from more detailed knowledge of microbe-host relationships during infection. Following M. tuberculosis infection, only 5-10...
Programme: FP7-HEALTH
Record Number: 88160
Last updated on: 2017-05-29
Access to Pharmaceuticals
[PROJEKT] ATP - Access to Pharmaceuticals
ID: 241839
Anfangsdatum: 2009-10-01, Enddatum: 2013-03-31
Access to Pharmaceuticals Equitable access to pharmaceuticals, particularly for developing countries is an essential human right. Various complex impediments hinder access, which is the subject of ongoing multidisciplinary studies. Intellectual Property and product developmen...
Programme: FP7-HEALTH
Record Number: 93051
Last updated on: 2017-05-25
ID: 5224
Anfangsdatum: 2005-01-01, Enddatum: 2009-12-31
ActinoGEN is an integrated project aimed at developing novel genomics-based approaches to exploit hitherto overlooked genetic resources for new antibiotics. Drug discovery will focus on (1) accessing new antibiotic biosynthetic pathways from diverse actinomycetes that have yet...
Record Number: 74037
Last updated on: 2009-06-03
List retrieved on: 2018-05-21
Folgen Sie uns auf: RSS Facebook Twitter YouTube Verwaltet vom Amt für Veröffentlichungen der EU Nach oben